New study indicates Vitamin D reduces the risk of ICU hospitalisation in Covid-19 patients

By - World Healthcare Journal

New research from Spain has found that a high dose of calcifediol, which is an activated form of vitamin D, can drastically reduce the risk of being placed into an ICU in Covid-19 patients.

The research itself was a peer-reviewed, randomised and controlled study of hospitalised patients at the University Hospital of Reina Sofia in Cordoba, Spain.

As part of the study, 50 of 76 hospitalised patients were treated with calcifediol, with the other group not receiving a dose.

The dosage of the calcifediol was measured in IU (international units) converted from vitamin D at a ratio of 200:1 micrograms. So, 10 micrograms of calcifediol are equivalent to 2000 IU of vitamin D. However, vitamin D3 has a 40:1 conversion rate for calcifediol.

Patients received very large doses of vitamin D, receiving 106,400 IU of vitamin D on day one, 53,200 IU on day three, 53,200 on day seven, and 53,200 once per week thereafter. For reference, the NHS recommends that adults need 10mg of Vitamin D per day, meaning patients received more than 53 times their recommended RDA of vitamin D (which we usually receive from sunlight alone) on the first day 

The results were remarkable. All patients who received calcifediol were later discharged without further complications, and only one required admission to the ICU.

“Of the 50 patients treated with calcifediol, one required admission to the ICU (2 per cent), while of 26 untreated patients, 13 required admission (50 per cent),” the study reads.

In the group who did not receive calcifediol, two patients died while in the ICU.

This study demonstrates that Calcifediol apparently reduces the severity of Covid-19, although larger-scale trials with balanced and matched groups will be necessary to definitively state that the treatment is effective for the wider population.

“Our pilot study demonstrated that administration of a high dose of calcifediol significantly reduced the need for ICU treatment of patients requiring hospitalisation due to proven Covid-19,” say the authors of the study.

This study emerges at a time where a Barcelona hospital is now letting patients admitted with Covid-19 out into the sunshine in a bid to increase their wellbeing and mental state, but with the findings of this study, patients may experience more than just a mental boost from the sunshine.

#whjnews #whjclinicaltrial #whjpharma #coronavirus #whjfabiansutch